Miguel Guzmán-RiveroAleida Verduguez-OrellanaK MontañoLieselotte CloetensErnesto RojasBjörn ÅkessonEdgar Sejas2026-03-222026-03-22201410.1016/j.biopha.2014.11.006https://doi.org/10.1016/j.biopha.2014.11.006https://andeanlibrary.org/handle/123456789/52192Citaciones: 5enImmune systemCutaneous leishmaniasisImmunologyPeripheral blood mononuclear cellCytokineCellular immunityInterleukin 2ZincMedicineInternal medicineThe immune response in patients with cutaneous leishmaniasis and the influence of zinc supplementationarticle